Relationship between Circulating and Tissue microRNAs in a Murine Model of Breast Cancer

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Waters, Peadar S ^a   McDermott, Ailbhe M ^a   Wall, Deirdre ^a   Heneghan, Helen M ^a   Miller, Nicola ^a   Newell, John ^a   Kerin, Michael J ^a   Dwyer, Roisin M ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 10B; MICRORNA 195; MICRORNA 221; MICRORNA 497; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST METASTASIS; CANCER CELL; CANCER GROWTH; CIRCULATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE LOCATION; LUNG; LYMPH NODE; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; QUANTITATIVE ANALYSIS; RNA EXTRACTION; TUMOR VOLUME;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INJECTIONS, SUBCUTANEOUS; LUNG; LYMPH NODES; MICE; MICE, NUDE; MICRORNAS; NEOPLASM TRANSPLANTATION; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

ANIMALIA; MURINAE; MUS MUSCULUS;

EID: 84870616787     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050459     Document Type: Article

References (54)

1. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, et al. (2000) Molecular portraits of human breast tumours. Nature 406: 747-752.
2. Kaplan HG, Malmgren JA, (2006) Disease-specific survival in patient-detected breast cancer. Clin Breast Cancer 7: 133-140.
3. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2009) Cancer statistics, 2009. CA Cancer J Clin 59: 225-249.
4. Carney PA, Miglioretti DL, Yankaskas BC, Kerlikowske K, Rosenberg R, et al. (2003) Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 138: 168-175.
5. Duffy MJ, (2006) Serum tumor markers in breast cancer: are they of clinical value? Clin Chem 52: 345-351.
6. Sturgeon CM, Lai LC, Duffy MJ, (2009) Serum tumour markers: how to order and interpret them. BMJ 339: b3527.
7. Harris L, Fritsche H, Mennel R, Norton L, Ravdin P, et al. (2007) American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 25: 5287-5312.
8. Calin GA, Liu CG, Sevignani C, Ferracin M, Felli N, et al. (2004) MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci U S A 101: 11755-11760.
9. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, et al. (2005) MicroRNA gene expression deregulation in human breast cancer. Cancer Res 65: 7065-7070.
10. Lehmann U, Hasemeier B, Christgen M, Muller M, Romermann D, et al. (2008) Epigenetic inactivation of microRNA gene hsa-mir-9-1 in human breast cancer. J Pathol 214: 17-24.
11. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103: 2257-2261.
12. Lawrie CH, Ballabio E, Dyar OJ, Jones M, Ventura R, et al. (2009) MicroRNA expression in chronic lymphocytic leukaemia. Br J Haematol 147: 398-402.
13. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, et al. (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 105: 10513-10518.
14. Heneghan HM, Miller N, Kelly R, Newell J, Kerin MJ, (2010) Systemic miRNA-195 differentiates breast cancer from other malignancies and is a potential biomarker for detecting noninvasive and early stage disease. Oncologist 15: 673-682.
15. Zhu W, Qin W, Atasoy U, Sauter ER, (2009) Circulating microRNAs in breast cancer and healthy subjects. BMC Res Notes 2: 89.
16. Ma L, Teruya-Feldstein J, Weinberg RA, (2007) Tumour invasion and metastasis initiated by microRNA-10b in breast cancer. Nature 449: 682-688.
17. Ma L, Reinhardt F, Pan E, Soutschek J, Bhat B, et al. (2010) Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol 28: 341-347.
18. Gee HE, Camps C, Buffa FM, Colella S, Sheldon H, et al. (2008) MicroRNA-10b and breast cancer metastasis. Nature 455: E8-9; author reply E9.
19. Negrini M, Calin GA, (2008) Breast cancer metastasis: a microRNA story. Breast Cancer Res 10: 203.
20. Pineau P, Volinia S, McJunkin K, Marchio A, Battiston C, et al. (2009) miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci U S A 107: 264-269.
21. Galardi S, Mercatelli N, Giorda E, Massalini S, Frajese GV, et al. (2007) miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1. J Biol Chem 282: 23716-23724.
22. Li D, Zhao Y, Liu C, Chen X, Qi Y, et al. (2011) Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer. Clin Cancer Res 17: 1722-1730.
23. Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J, et al. (2010) Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 251: 499-505.
24. Zhao R, Wu J, Jia W, Gong C, Yu F, et al. (2011) Plasma miR-221 as a predictive biomarker for chemoresistance in breast cancer patients who previously received neoadjuvant chemotherapy. Onkologie 34: 675-680.
25. Esquela-Kerscher A, Slack FJ, (2006) Oncomirs- microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269.
26. Lima LG, Chammas R, Monteiro RQ, Moreira ME, Barcinski MA, (2009) Tumor-derived microvesicles modulate the establishment of metastatic melanoma in a phosphatidylserine-dependent manner. Cancer Lett 283: 168-175.
27. Cocucci E, Racchetti G, Meldolesi J, (2009) Shedding microvesicles: artefacts no more. Trends Cell Biol 19: 43-51.
28. Ghosh AK, Secreto CR, Knox TR, Ding W, Mukhopadhyay D, et al. (2009) Circulating microvesicles in B-cell chronic lymphocytic leukemia can stimulate marrow stromal cells: implications for disease progression. Blood 115: 1755-1764.
29. Davoren PA, McNeill RE, Lowery AJ, Kerin MJ, Miller N, (2008) Identification of suitable endogenous control genes for microRNA gene expression analysis in human breast cancer. BMC Mol Biol 9: 76.
30. Lowery AJ, Miller N, McNeill RE, Kerin MJ, (2008) MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management. Clin Cancer Res 14: 360-365.
31. Livak KJ, Schmittgen TD, (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
32. Hedeker D, Mermelstein RJ, Demirtas H, (2007) Analysis of binary outcomes with missing data: missing = smoking, last observation carried forward, and a little multiple imputation. Addiction 102: 1564-1573.
33. Li D, Zhao Y, Liu C, Chen X, Qi Y, et al. (2011) Analysis of MiR-195 and MiR-497 expression, regulation and role in breast cancer. Clin Cancer Res 17: 1722-1730.
34. Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J, et al. (2010) Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 251: 499-505.
35. Ma L, Reinhardt F, Pan E, Soutschek J, Bhat B, et al. (2010) Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model. Nat Biotechnol 28: 341-347.
36. Zhao R, Wu J, Jia W, Gong C, Yu F, et al. (2011) Plasma miR-221 as a predictive biomarker for chemoresistance in breast cancer patients who previously received neoadjuvant chemotherapy. Onkologie 34: 675-680.
37. Xiao J, Liang D, Zhang Y, Liu Y, Zhang H, et al. (2011) MicroRNA expression signature in atrial fibrillation with mitral stenosis. Physiol Genomics 43: 655-664.
38. Soci UP, Fernandes T, Hashimoto NY, Mota GF, Amadeu MA, et al. (2010) MicroRNAs 29 are involved in the improvement of ventricular compliance promoted by aerobic exercise training in rats. Physiol Genomics 43: 665-673.
39. Christensen M, Schratt GM, (2009) microRNA involvement in developmental and functional aspects of the nervous system and in neurological diseases. Neurosci Lett 466: 55-62.
40. Shafi G, Aliya N, Munshi A, (2010) MicroRNA signatures in neurological disorders. Can J Neurol Sci 37: 177-185.
41. Saito Y, Suzuki H, Hibi T, (2009) The role of microRNAs in gastrointestinal cancers. J Gastroenterol 44Suppl 19: 18-22.
42. Wu F, Guo NJ, Tian H, Marohn M, Gearhart S, et al. (2010) Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn's disease. Inflamm Bowel Dis 17: 241-250.
43. Price JE, Polyzos A, Zhang RD, Daniels LM, (1990) Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res 50: 717-721.
44. Nakata K, Ohuchida K, Mizumoto K, Kayashima T, Ikenaga N, et al. (2011) MicroRNA-10b is overexpressed in pancreatic cancer, promotes its invasiveness, and correlates with a poor prognosis. Surgery 150: 916-922.
45. Liu Z, Zhu J, Cao H, Ren H, Fang X, (2012) miR-10b promotes cell invasion through RhoC-AKT signaling pathway by targeting HOXD10 in gastric cancer. Int J Oncol 40: 1553-1560.
46. Li X, Zhang Y, Ding J, Wu K, Fan D, (2010) Survival prediction of gastric cancer by a seven-microRNA signature. Gut 59: 579-585.
47. Nishida N, Yamashita S, Mimori K, Sudo T, Tanaka F, et al. (2012) MicroRNA-10b is a Prognostic Indicator in Colorectal Cancer and Confers Resistance to the Chemotherapeutic Agent 5-Fluorouracil in Colorectal Cancer Cells. Ann Surg Oncol.
48. Wurz K, Garcia RL, Goff BA, Mitchell PS, Lee JH, et al. (2010) MiR-221 and MiR-222 alterations in sporadic ovarian carcinoma: Relationship to CDKN1B, CDKNIC and overall survival. Genes Chromosomes Cancer 49: 577-584.
49. Zheng C, Yinghao S, Li J (2011) MiR-221 expression affects invasion potential of human prostate carcinoma cell lines by targeting DVL2. Med Oncol.
50. Miller TE, Ghoshal K, Ramaswamy B, Roy S, Datta J, et al. (2008) MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1. J Biol Chem 283: 29897-29903.
51. Visone R, Russo L, Pallante P, De Martino I, Ferraro A, et al. (2007) MicroRNAs (miR)-221 and miR-222, both overexpressed in human thyroid papillary carcinomas, regulate p27Kip1 protein levels and cell cycle. Endocr Relat Cancer 14: 791-798.
52. Shah MY, Calin GA, (2011) MicroRNAs miR-221 and miR-222: a new level of regulation in aggressive breast cancer. Genome Med 3: 56.
53. Yaman Agaoglu F, Kovancilar M, Dizdar Y, Darendeliler E, Holdenrieder S, et al. (2011) Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer. Tumour Biol 32: 583-588.
54. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, et al. (2002) Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 99: 15524-15529.